Generic Reglan makers released from Tardive Dyskinesia lawsuit
Wyeth, Inc. and Schwarz Pharma Inc. have been dismissed from a lawsuit filed in Texas involving the drug company’s Reglan (metoclopramide), a medicine used to treat gastrointestinal conditions. The lawsuit alleged that the drug caused the plaintiff to develop a severe movement disorder known as Tardive Dyskinesia. However, the case will proceed against Activis-Elizabeth, L.L.C., makers of a generic version of metoclopramide that the plaintiff was taking.
![[ Beasley Allen Law Firm Logo ]](http://www.reglan-lawyer.net/wp-content/themes/system-unity/images/logo.png)

Surgery was all Mary Carter could hope for. The 27-year-old lover of food wanted to be able to eat again. But after a brief illness, she was unable to eat without becoming ill. She suffered from gastroparesis, a condition in which the stomach takes too long to empty its contents. It can cause serious problems for sufferers, including dehydration and malnutrition.
If 27-year-old Mary Carter had her wish, she would be a food critic. But instead of enjoying lavish meals in fine restaurants, she gets her nutrition through a feeding tube. Mary remembers when her life changed so dramatically. It was August 1, 2006, and she was driving in her car. She began to feel nauseous, her heart raced, and her vision became blurry. From that moment on, everything she put in her mouth she would vomit up.
Kecia Neal of Arkansas was prescribed